BPG is committed to discovery and dissemination of knowledge
Featured Articles
2/3/2026 7:05:21 AM | Browse: 248 | Download: 754
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 115562
Country China
Received
2025-10-24 12:29
Peer-Review Started
2025-10-24 12:29
First Decision by Editorial Office Director
2025-11-05 07:45
Return for Revision
2025-11-05 07:45
Revised
2025-11-13 08:29
Publication Fee Transferred
2025-11-18 09:08
Editorial Processing by Scientific Editor
2025-12-11 02:46
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-12-11 08:13
Articles in Press
2025-12-11 08:13
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-01-26 08:26
Publish the Manuscript Online
2026-02-03 06:28
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Retrospective Study
Article Title Clinical characteristics of programmed death-1 inhibitors for older patients with advanced pancreatic cancer
Manuscript Source Unsolicited Manuscript
All Author List Yun-Yun Lu, Pan Chen and Yi Lu
Funding Agency and Grant Number
Corresponding Author Yun-Yun Lu, Department of Radiation Oncology, Ningbo Medical Center Lihuili Hospital, No. 1111 Jiangnan Road, Ningbo 315048, Zhejiang Province, China. lhlluyunyun@nbu.edu.cn
Key Words Advanced pancreatic cancer; Older adults; Programmed death-1 inhibitors; Eastern Cooperative Oncology Group performance status; Prognostic nutritional index; Triglyceride
Core Tip This study identified prognostic factors for older patients with advanced pancreatic cancer treated with programmed death-1 (PD-1) inhibitors. The findings indicated that PD-1 inhibitor therapy was safe in this older population. Key predictors of treatment prognosis included the Eastern Cooperative Oncology Group performance status, prognostic nutritional index, and triglyceride levels.
Publish Date 2026-02-03 06:28
Citation

Lu YY, Chen P, Lu Y. Clinical characteristics of programmed death-1 inhibitors for older patients with advanced pancreatic cancer. World J Gastrointest Oncol 2026; 18(2): 115562

URL https://www.wjgnet.com/1948-5204/full/v18/i2/115562.htm
DOI https://dx.doi.org/10.4251/wjgo.v18.i2.115562
Full Article (PDF) WJGO-18-115562-with-cover.pdf